Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Eoflow (294090 KS)
Watchlist
134
Analysis
Health Care
•
South Korea
Eoflow Co.,Ltd. develops and sells medical devices. The Company produces and sells wearable disposable insulin pumps and other products. Eoflow markets its products throughout Korea.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hollysys Automation Technologies
•
03 Dec 2023 07:00
(Mostly) Asia-Pac Weekly Risk Arb Wrap: Glosel, CIMC, Orecorp, Tietto Mineral, Lansen Pharmaceutical
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
389 Views
Share
bullish
•
Taisho Pharmaceutical Holdin
•
01 Dec 2023 08:51
(Mostly) Asia M&A, Nov 2023: Taisho Pharma, CIMC Vehicle, CMIC, Japan Best Rescue, Shidax
For the month of November, 16 new deals were discussed on Smartkarma with an overall deal size of ~US$13bn. The average premium for the new deals...
David Blennerhassett
Follow
495 Views
Share
bearish
•
Origin Energy
•
27 Nov 2023 00:18
Merger Arb Mondays (27 Nov) - Origin, OreCorp, Healius, Taisho, JSR, Eoflow, Hollysys, Haitong Intl
This week, the highest gross spreads are Eoflow (218%), 111 (69.4%), Taisho Pharma (55.5%), Healius (48.0%), IRC (20.4%), Hollysys (12.8%), Origin...
Arun George
Follow
590 Views
Share
bullish
•
JSR Corp
•
26 Nov 2023 09:52
Weekly Deals Digest (26 Nov) - JSR, Taisho, Origin, OreCorp, Eoflow, Hollysys, Zeekr, Tata Tech
Last week, notable developments occurred in Event-Driven (JSR, Taisho, Origin Energy, OreCorp, Eoflow, Hollysys, Haitong Intl, UMW) and ECM (Asahi,...
Arun George
Follow
458 Views
Share
bullish
•
JSR Corp
•
26 Nov 2023 07:05
Last Week in Event SPACE: JSR, Prosus/Tencent, Hollysys, Tata Consultancy, Geely, EOFlow
The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...
David Blennerhassett
Follow
437 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x